Clinical trial
Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
NCT00445705 · Allergan, Industry · Terminated
Key facts
| NCT number | NCT00445705 |
|---|---|
| Title | Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome |
| Lead sponsor | Allergan, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | placebo, AGN 203818 |
| Enrollment | 211 |
| Start date | Mar 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Mar 9, 2007 |
| Last update posted | Sep 7, 2015 |
| Countries | Switzerland, United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: